Skip to main content

Table 2 Psychological measures, health-related behaviours and SU target

From: Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

 

At SU target (<0.36 mmol/L)

Above SU target (≥0.36 mmol/L)

p

n = 89

n = 184

Confidence to keep serum urate under control, mean (SD)

7.4 (2.4)

6.7 (2.7)

0.02

Confidence to follow diet, mean (SD)

7.5 (2.3)

7.4 (2.3)

0.76

Confidence to have blood tests at recommended frequency, mean (SD)

9.4 (1.1)

9.0 (2.0)

0.06

Confidence to take gout medications regularly, mean (SD)

9.5 (1.4)

9.0 (1.7)

0.03

BIPQ treatment control score, mean (SD)

8.2 (2.4)

7.4 (2.8)

0.02

BIPQ personal control score, mean (SD)

6.1 (3.1)

5.5 (3.1)

0.18

BIPQ understanding score, mean (SD)

7.3 (2.6)

6.5 (2.8)

0.04

Adherence score (those on ULT only), mean (SD)

42.7 (2.7)

39.0 (7.4)

<0.001

  1. BIPQ: brief illness perception questionnaire.